124 related articles for article (PubMed ID: 35818168)
21. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182.
Li Q; Xing W; Gong X; Wang Y
Cell Physiol Biochem; 2018; 51(3):1149-1163. PubMed ID: 30481751
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Smurf2 translation by miR-322/503 protects from ischemia-reperfusion injury by modulating EZH2/Akt/GSK3β signaling.
Dong W; Xie F; Chen XY; Huang WL; Zhang YZ; Luo WB; Chen J; Xie MT; Peng XP
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C253-C261. PubMed ID: 30649914
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
26. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract][Full Text] [Related]
27. CXCR6 promotes tumor cell proliferation and metastasis in osteosarcoma through the Akt pathway.
Ma Y; Xu X; Luo M
Cell Immunol; 2017 Jan; 311():80-85. PubMed ID: 27823764
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
Liu Y; Cheng Z; Pan F; Yan W
Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
30. GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.
Ko HW; Lee HH; Huo L; Xia W; Yang CC; Hsu JL; Li LY; Lai CC; Chan LC; Cheng CC; Labaff AM; Liao HW; Lim SO; Li CW; Wei Y; Nie L; Yamaguchi H; Hung MC
Oncotarget; 2016 Aug; 7(35):57131-57144. PubMed ID: 27494834
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of hsa_circ_0007534 predicts unfavorable prognosis for osteosarcoma and regulates cell growth and apoptosis by affecting AKT/GSK-3β signaling pathway.
Li B; Li X
Biomed Pharmacother; 2018 Nov; 107():860-866. PubMed ID: 30142548
[TBL] [Abstract][Full Text] [Related]
32. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
33. Propofol suppresses osteosarcoma cell function by regulating FOXO1/TUSC7.
Huang X; Liu J; Xie H
J Pharm Pharmacol; 2021 Apr; 73(6):720-725. PubMed ID: 33724400
[TBL] [Abstract][Full Text] [Related]
34. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
35. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.
Lu K; Wang X; Chen Y; Liang D; Luo H; Long L; Hu Z; Bao J
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):456-464. PubMed ID: 29546355
[TBL] [Abstract][Full Text] [Related]
36. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.
Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y
J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209
[TBL] [Abstract][Full Text] [Related]
38. miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.
Liu H; Wei W; Wang X; Guan X; Chen Q; Pu Z; Xu X; Wei A
Mol Med Rep; 2018 Dec; 18(6):5683-5692. PubMed ID: 30387818
[TBL] [Abstract][Full Text] [Related]
39. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
40. Schisandrin B suppresses osteosarcoma lung metastasis
Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
